Literature DB >> 1415216

Evidence for genetic heterogeneity in tuberous sclerosis: one locus on chromosome 9 and at least one locus elsewhere.

H Northrup1, D J Kwiatkowski, E S Roach, W B Dobyns, R A Lewis, G E Herman, E Rodriguez, S P Daiger, S H Blanton.   

Abstract

Linkage of tuberous sclerosis complex (TSC), an autosomal dominant disorder, to markers on chromosome 9 was reported first in 1987. This assignment was confirmed by an international collaborative study that suggested more than one locus may be responsible for the phenotype. We studied 14 multigenerational TSC families (13 previously unreported) with markers for nine loci in the linked region of chromosome 9q32-q34. Our results confirm the previous reports that the genetic locus in one-third to one-half of families maps to chromosome 9. Comparison of clinical findings in the chromosome 9-linked families with those in the chromosome 9-unlinked families reveals only a higher incidence of ungual fibromata in the chromosome 9-linked families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1415216      PMCID: PMC1682771     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Construction of a GT polymorphism map of human 9q.

Authors:  D J Kwiatkowski; E P Henske; K Weimer; L Ozelius; J F Gusella; J Haines
Journal:  Genomics       Date:  1992-02       Impact factor: 5.736

2.  Estimating the power of a proposed linkage study for a complex genetic trait.

Authors:  L M Ploughman; M Boehnke
Journal:  Am J Hum Genet       Date:  1989-04       Impact factor: 11.025

3.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

4.  Linkage of the tuberous sclerosis locus to a DNA polymorphism detected by v-abl.

Authors:  J M Connor; L A Pirrit; J R Yates; A E Fryer; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1987-09       Impact factor: 6.318

5.  Genetic heterogeneity in tuberous sclerosis. Study of a large collaborative dataset.

Authors:  J L Haines; J Amos; J Attwood; N T Bech-Hansen; M Burley; P M Conneally; J M Connor; R Fahsold; P Flodman; A Fryer
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

6.  Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

Authors:  M Mahadevan; C Tsilfidis; L Sabourin; G Shutler; C Amemiya; G Jansen; C Neville; M Narang; J Barceló; K O'Hoy
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

7.  An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

Authors:  Y H Fu; A Pizzuti; R G Fenwick; J King; S Rajnarayan; P W Dunne; J Dubel; G A Nasser; T Ashizawa; P de Jong
Journal:  Science       Date:  1992-03-06       Impact factor: 47.728

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982.

Authors:  W C Wiederholt; M R Gomez; L T Kurland
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  9 in total

1.  Computer simulation of linkage and heterogeneity in tuberous sclerosis: a critical evaluation of the collaborative family data.

Authors:  L A Janssen; L A Sandkuijl; J R Sampson; D J Halley
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

2.  Report of a critical recombination further narrowing the TSC1 region.

Authors:  K S Au; J Murrell; A Buckler; S H Blanton; H Northrup
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

3.  Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.

Authors:  K S Au; J A Rodriguez; J L Finch; K A Volcik; E S Roach; M R Delgado; E Rodriguez; H Northrup
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

4.  Molecular analysis of the human vitamin D binding protein (group specific component, Gc) in tuberous sclerosis complex (TSC).

Authors:  J A Rodriguez; R L Evans; S P Daiger; H Northrup
Journal:  J Med Genet       Date:  1997-06       Impact factor: 6.318

5.  Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions.

Authors:  E P Henske; B W Scheithauer; M P Short; R Wollmann; J Nahmias; N Hornigold; M van Slegtenhorst; C T Welsh; D J Kwiatkowski
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  Tsc1 Haploinsufficiency Leads to Pax2 Dysregulation in the Developing Murine Cerebellum.

Authors:  Ines Serra; Ana Stravs; Catarina Osório; Maria Roa Oyaga; Martijn Schonewille; Christian Tudorache; Aleksandra Badura
Journal:  Front Mol Neurosci       Date:  2022-05-13       Impact factor: 6.261

7.  Identification of a nonsense mutation at the 5' end of the TSC2 gene in a family with a presumptive diagnosis of tuberous sclerosis complex.

Authors:  R Vrtel; S Verhoef; K Bouman; M M Maheshwar; M Nellist; A J van Essen; P L Bakker; C J Hermans; M T Bink-Boelkens; R M van Elburg; M Hoff; D Lindhout; J Sampson; D J Halley; A M van den Ouweland
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

8.  Refined localization of TSC1 by combined analysis of 9q34 and 16p13 data in 14 tuberous sclerosis families.

Authors:  B Janssen; J Sampson; M van der Est; W Deelen; S Verhoef; I Daniels; A Hesseling; P Brook-Carter; M Nellist; D Lindhout
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

9.  Phenotypic variation of tuberous sclerosis in a single extended kindred.

Authors:  S L Smalley; F Burger; M Smith
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.